Although the thymus was well recognised in ancient times, (it was known to the ancient Egyptians), its exact function and the indications for its removal, thymectomy, have only been determined in recent times; well within the memory of the older members of the healthcare professions. Indeed, when I taught about the thymus as a young Professor of Surgery, I had to admit, much to the delight of my students, my ignorance of the subject! The thymus was directly referred to by Rufus of Ephesus, about AD 100, who noted that 'the thymus is situated under the head of the heart, oriented towards the seventh vertebra of the neck and towards the end of the trachea'. Its structure was described in more detail by that great Greek physician, Galen (129-216 AD), who believed it played a part in the purification of the nervous system. He noted, accurately, that the structure was large in young animals and dwindled in size with growth. The term 'Thymus' is probably derived from its resemblance to a plant of the same name.
That father of modern anatomy, Andreas Vesalius, Professor of Anatomy at the University of Padua, in his landmark anatomical textbook, The Fabric of the Human Body (1543), believed that the thymus acted as a protective cushion to the great vessels in the superior mediastinum. In 1832, the Guy's Hospital surgeon, Sir Astley Cooper, at the age of 64, published a superbly illustrated monograph on the thymus and showed, by injecting mercury into the thymus of the fetal calf, lymphatic channels draining into the innominate (brachiocephalic) veins in the mediastinum.
In 1846 an English physician and chemist, Arthur Hassall, published his two volume treatise Microscopic anatomy of the human body in health and disease. This was the first study in English to distinguish between the microscopic appearances of lymph nodes and the thymus. Hassall identified the clumps of epitheliod reticular cells in the thymic medulla which, to this day, are referred to as 'Hassall's corpuscles'.
Towards the end of the 19th century, now that death notification had become compulsory, the label 'status lymphaticus' became useful; an infant would die suddenly, an autopsy would be performed, a large thymus noted and a convenient title of 'status lymphaticus' appended to the death certificate! The discovery of X-rays by Conrad Roentgen in 1896 was soon followed by the observation of the shadow of the large thymus of the baby being visible on its chest X-ray. Indeed, a number of children with a variety of symptoms were submitted to thymectomy, performed through a low cervical incision, resembling that used for thyroidectomy. Other infants were treated by X-radiation; some of these unfortunates went on to develop radiation-induced malignancies. It was not until 1931 that The Lancet published a leading article entitled The End of Status Lymphaticus; yet another mythical disease henceforth disappeared! Now we come to an intriguing part of the thymus story when two conditions, both rare in themselves, were found to overlap each other in what remains something of a mysterious coincidence. First are tumours of the thymus gland. These are indeed uncommon and I have not personally encountered an example in forty years of surgical practice. Thymomas may be benign or malignant and rapidly invasive. They may originate from the epitheliod cells of Hassal's corpuscles or from the lymphoid thymic tissue.
Second, the condition of myasthenia gravis, a disease in which the end plates of the nerve endings in voluntary, striated, muscle become resistant to the action of acetyl choline, the chemical which initiates muscle contraction. This disease is characterised by weakness of the voluntary muscles, especially the extrinsic muscles of the eye, which results in ptosis, or drooping, of the eye lids. The majority of these patients can be managed medically by choline esterase inhibitors such as pyridostigmine. (Choline esterase is the chemical released at the motor nerve endings in the muscles.) Now, the extraordinary fact is that about 15% of patients with myasthenia gravis also have a tumour of the thymus gland! In 1936, Alfred Blalock of the Johns Hopkins Hospital, Baltimore, (who went on to devise the shunt operation for 'blue babies' suffering from Fallot's tetralogy), performed a thymectomy on a girl of 19 who had a thymic tumour. Coincidentally, she also had myasthenia gravis; following surgery, her myasthenia was relieved. By 1941, Blalock was able to report that he had removed the normal thymus in six patients suffering from myasthenia with favourable results in all the cases.
A year after Blalock's work, Sir Geoffrey Keynes of St. Bartholomew's Hospital, London, working at the Thyroid Clinic at New End Hospital in Hampstead, carried out a thymectomy on a female patient aged 37 with end-stage myasthenia. Ten years later she was in good health. By 1952, Keynes was able to record 250 thymectomies on myasthenic patients. Roughly one third of these were well, with no adjuvant drugs, one third required small maintenance doses of prostigmine and one third were improved but still required large drug supplements Thymectomy remains a treatment option for myasthenic patients, especially today, when modern imaging can now demonstrate those with a thymic tumour.
But now we reach the latest part of the thymus story, the work of the Australian biologist J. Miller, on the actual function of this mysterious gland. By 1962 he was able to show, by his experiments on mice thymectomised at birth, that the thymus is responsible for the cellular component of the immune system of the body via the thymic derived cells (T-cells). A second subset of cells, derived from the bone marrow (B-cells) is responsible for the production of antibodies.
It seems that now, after so many centuries, the mysteries of the thymus gland have been to a great extent resolved! No competing interests declared
